Neuroimaging markers of human immunodeficiency virus infection in South Africa

Journal of NeuroVirology

Volumn 18, Issue 3, 2012, Pages 151-156

  Heaps, Jodi M ^a   Joska, John ^b   Hoare, Jackie ^b   Ortega, Mario ^c   Agrawa, Aleena ^c   Seedat, Soraya ^d   Ances, Beau M ^c   Stein, Dan J ^b   Paul, Robert ^a  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Clade C virus; HIVinfection; Neuroimaging; South Africa

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CLADISTICS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; GENETIC VARIABILITY; GRAY MATTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE PROCESSING; MALE; NEUROIMAGING; PRIORITY JOURNAL; SOUTH AFRICA; SUBCORTEX; THALAMUS; VOLUMETRY; WHITE MATTER;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; BRAIN; CD4 LYMPHOCYTE COUNT; COGNITION; FEMALE; HIV; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; SOUTH AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84863645926     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-012-0090-5     Document Type: Article

References (33)

1. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ (2004). HIV and hepatitis C coinfection within the CAESAR study. HIV. Med 5:174-179. (Pubitemid 38765285)
2. Ances BA, Ortega M, Vaida F, Heaps J, Paul R (2012) Independent. effects of HIV, aging, and HAART on brain volumetric. measures. JAIDS. Post acceptance 20 Jan 2012, doi:10.1097/QAI.0b013e318249db17.
3. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans. S (2007) Neurological evaluation of untreated human immunodeficiency. virus infected adults in Ethiopia. J Neurovirol 13:67-72. doi:10.1080/13550280601169837. (Pubitemid 46510146)
4. Constantino AA, Huang Y, Zhang H, Wood C, Zheng JC (2011) HIV-1. clade B and C isolates exhibit differential replication: relevance to. macrophage-mediated neurotoxicity. Neurotox Res 20:277-288. doi:10.1007/s12640- 011-9241-3.
5. Elovaara I, Poutiainen E, Raininko R, Valanne L, Virta A, Valle SL, Lahdevirta J, Iivanainen M (1990) Mild brain atrophy in early HIV. infection: the lack of association with cognitive deficits and HIVspecific. intrathecal immune response. J Neurol Sci 99:121-136. (Pubitemid 20387371)
6. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van. der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation:. automated labeling of neuroanatomical structures in the human. brain. Neuron 33:341-355. (Pubitemid 34162530)
7. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn. BT, Dale AM (2004) Sequence-independent segmentation of. magnetic resonance images. Neuroimage 23(SUPPL. 1):S69-S84. doi:10.1016/j.neuroimage.2004.07.016. (Pubitemid 39429376)
8. Gandhi N, Saiyed Z, Thangavel S, Rodriguez J, Rao KV, Nair MP. (2009) Differential effects of HIV type 1 clade B and clade C Tat. protein on expression of proinflammatory and antiinflammatory. cytokines by primary monocytes. AIDS Res Hum Retroviruses. 25:691-699. doi:10.1089/aid.2008.0299.
9. Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007) Neuropsychological. deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol. 13:195-202. doi:10.1080/13550280701258407. (Pubitemid 47053787)
10. Hoare J, Fouche JP, Spottiswoode B, Sorsdahl K, Combrinck M, Stein DJ, Paul RH, Joska JA (2011) White-matter damage in clade C HIVpositive. subjects: a diffusion tensor imaging study. J Neuropsychiatry. Clin Neurosci 23:308-315. doi:10.1176/appi.neuropsych.23.3.308.
11. JacobsGB, Laten A, van Rensburg EJ, BodemJ,Weissbrich B, Rethwilm. A, Preiser W, Englebrecht S (2008) Phylogenetic diversity and low. level antiretroviral resistance mutations in HIV type 1 treatmentnaive. patients from Cape Town, South Africa. AIDS Res Hum. Retroviruses 24:1009-1012. doi:10.1089/aid.2008.0028.
12. Jacobs GB, LoxtonAG, LatenA, Robson B, van Rensburg EJ, Engelbrecht. S (2009) Emergence and diversity of different HIV-1 subtypes in. South Africa, 2000-2001. J Med Virol 81:1852-1859. doi:10.1002/jmv.21609.
13. Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S (2009) Clinical. correlates of HIV-associated neurocognitive disorders in South. Africa. AIDS Behav 14:371-378. doi:10.1007/s10461-009-9538-x.
14. Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ (2010a) Does highly. active antiretroviral therapy improve neurocognitive function? A. systematic review. J Neurovirol 16:101-114. doi:10.3109/13550281003682513.
15. Joska JA,Westgarth-Taylor J,Myer L, Hoare J, Thomas KG, Combrinck. M, Paul RH, Stein DJ, Flisher AJ (2010b) Characterization of HIVassociated. neurocognitive disorders among individuals starting antiretroviral. therapy in South Africa. AIDS Behav 15:1197-1203. doi:10.1007/s10461-010-9744-6.
16. Kieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED (1996) Cognitive performance and. regional brain volume in human immunodeficiency virus type 1.infection. Arch Neurol 53:155-158. (Pubitemid 26055262)
17. Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL (2010) HIVassociated. neurocognitive disorder: pathogenesis and therapeutic. opportunities. J Neuroimmune Pharmacol 5:294-309. doi:10.1007/s11481-010-9205-z.
18. Liner KJ 2nd, Ro MJ, Robertson KR (2010) HIV, antiretroviral therapies, and the brain. Curr HIV/AIDS Rep 7:85-91. doi:10.1007/s11904-010-0042-8.
19. Patel SH, Kolson DL, Glosser G, Matozzo I, Ge Y, Babb JS, Mannon. LJ, Grossman RI (2002) Correlation between percentage of brain. parenchymal volume and neurocognitive performance in HIVinfected. patients. AJNR Am J Neuroradiol 23:543-549. (Pubitemid 34411906)
20. Paul R, Cohen R, Navia B, Tashima K (2002) Relationships between. cognition and structural neuroimaging findings in adults with. human immunodeficiency virus type-1. Neurosci Biobehav Rev. 26:353-359. (Pubitemid 34553318)
21. Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran. R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004) Tat protein of human immunodeficiency. virus type 1 subtype C strains is a defective chemokine. J. Virol 78:2586-2590. (Pubitemid 38228954)
22. Rao VR, Sas AR, Eugenin EA, Siddappa NB, Bimonte-Nelson H, Berman JW, Ranga U, Tyor WR, Prasad VR (2008) HIV-1. clade-specific differences in the induction of neuropathogenesis. J Neurosci 28:10010-10016. doi:10.1523/ JNEUROSCI.2955-08.2008.
23. Riedel D, Ghate M, Nene M, Paranjape R, Mehendale S, Bollinger R, Sacktor N, McArthur J, Nath A (2006) Screening for human immunodeficiency. virus (HIV) dementia in an HIV clade C-infected. population in India. J Neurovirol 12:34-38. doi:10.1080/13550280500516500.
24. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi. S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The. International HIV Dementia Scale: a new rapid screening test for. HIV dementia. AIDS 19:1367-1374. (Pubitemid 41800672)
25. Samikkannu T, Agudelo M, Gandhi N, Reddy PV, Saiyed ZM, Nwankwo D, Nair MP (2011) Human immunodeficiency virus. type 1 clade B and C gp120 differentially induce neurotoxin. arachidonic acid in human astrocytes: implications for neuro-AIDS. J Neurovirol 17:230-238. doi:10.1007/s13365-011- 0026-5.
26. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi. V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK (2000). Profile of neurologic disorders associated with HIV/AIDS from. Bangalore, South India (1989-96). Indian J Med Res 111:14-23. (Pubitemid 30213883)
27. Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, Singer E, Levine AJ, Minagar A, Novembre FJ, Somboonwit C, Nath A, Sinnott JT (2011) Editorial neuroAIDS review. AIDS. 25:123-141. doi:10.1097/QAD.0b013e328340fd42.
28. Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT (2005) Thinning of the cerebral cortex. visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. QProc Natl Acad Sci USA 102:15647-15652. doi:10.1073/pnas.0502548102. (Pubitemid 41528110)
29. Thurnher MM, Donovan Post MJ (2008) Neuroimaging in the brain in. HIV-1-infected patients. Neuroimaging Clin N Am 18:93-117. doi:10.1016/j.nic. 2007.12.013, viii.
30. Tucker KA, Robertson KR, Lin W, Smith JK, An H, Chen Y, Aylward. SR, Hall CD (2004) Neuroimaging in human immunodeficiency. virus infection. J Neuroimmunol 157:153-162. doi:10.1016/j.jneuroim.2004.08.036. (Pubitemid 39576650)
31. Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, Gee JC (2010) N4ITK: improved N3 bias correction. IEEE Trans. Med Imaging 29:1310-1320. doi:10.1109/TMI.2010.2046908.
32. Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon. S, Flanigan T (2006) Neurocognitive consequences of HIV in. southern India: a preliminary study of clade C virus. J Int Neuropsychol. Soc: JINS 12:424-430. (Pubitemid 43970908)
33. Zatz LM, Jernigan TL (1983) The ventricular-brain ratio on computed. tomography scans: validity and proper use. Psychiatry Res 8:207-214 (Pubitemid 13121110)